(Q39422353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28688236%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

review article

1 reference

title

Antigen-specific regulatory T cells: are police CARs the answer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28688236%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28688236%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Megan K. Levings

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28688236%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

author name string

Nicholas A J Dawson

series ordinal

1

1 reference

11 September 2017

Megan K Levings

series ordinal

2

1 reference

11 September 2017

publication date

19 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28688236%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28688236%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

volume

187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28688236%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

53-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28688236%20AND%20SRC:MED&resulttype=core&format=json

Hurdles in therapy with regulatory T cells

24 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Specificity of CD4+CD25+ regulatory T cell function in alloimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Infectious tolerance: therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

How regulatory T cells work

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Redirecting human CD4+CD25+ regulatory T cells from the peripheral blood with pre-defined target specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

The self-obsession of T cells: how TCR signaling thresholds affect fate 'decisions' and effector function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Signals and pathways controlling regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Regulatory T cells require TCR signaling for their suppressive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Continuous T cell receptor signals maintain a functional regulatory T cell pool.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Continuous requirement for the TCR in regulatory T cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Discarded Human Thymus Is a Novel Source of Stable and Long-Lived Therapeutic Regulatory T Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Chimeric antigen receptors: driving immunology towards synthetic biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

Regulatory T cell therapy for type 1 diabetes: May the force be with you.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2017.06.009

10.1016/J.TRSL.2017.06.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28688236%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference